IVD Medical Holding Limited (1931.HK) HKSE
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In HKD
Sector
Healthcare
Industry
Medical - Distribution
Employees
863
First IPO Date
July 12, 2019
| Name | Title | Pay | Year Born |
| Siu Kei Chan | Executive Director & Company Secretary | 1.1M | 1984 |
| Xianya Lin | GM & Executive Director | 3.27M | 1976 |
| Bo Yang | Financial Controller | 0 | 1978 |
| Xiao Yi | Chief Scientist & Executive Director | 0 | 1994 |
IVD Medical Holding Limited functions as an investment holding company primarily engaged in the distribution of in vitro diagnostic (IVD) products. Its operations span both Mainland China and global markets. The enterprise structures its activities into three key segments: a Distribution Business, Maintenance Services, and a Self-branded Products Business. The company offers a comprehensive range of IVD analysers, reagents, and other consumables. These are utilized across various diagnostic testing fields, including hematology and body fluid analysis, immunoassay, clinical chemistry, molecular diagnostics, microbiology, and point-of-care testing. Additionally, it supplies haemostasis products and provides specialized solution services for clinical laboratories within hospitals. Its maintenance services include repair, installation, and training for end customers. Under its proprietary IVD brand, the company actively researches, develops, manufactures, and markets IVD analyzers and reagents. Its clientele encompasses hospitals, various healthcare institutions, logistics partners, and independent distributors. Established in 1993, IVD Medical Holding Limited maintains its headquarters in Shanghai, People's Republic of China.